{
  "type": "hyp",
  "text": "These patients had primarily relapsed diffuse large B-cell lymphoma (63%) were heavily pretreated (median of three regimens) and high risk (79% international prognostic index greater than or=2) and 34% were relapsed after autologous stem cell transplant.\n",
  "self": {
    "NER": {
      "answers": [
        "63%",
        "three",
        "79%",
        "34%"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What percentage of patients had relapsed diffuse large B-cell lymphoma?",
          "How many regimens were used to treat the patients with relapsed B-cell lymph",
          "What was the international prognostic index of high risk patients?",
          "What percentage of patients had relapsed after autologous stem cell transplant?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "These patients",
        "diffuse",
        "large B-cell lymphoma",
        "63%",
        "median",
        "high risk",
        "79% international prognostic index",
        "34%",
        "autologous stem cell transplant"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What patients had a high risk of relapsed diffuse large B-cell lympho",
          "What type of large B-cell lymphoma was most common in the relapse",
          "What type of lymphoma was most commonly seen in the relapsed patients?",
          "What percentage of patients had relapsed diffuse large B-cell lymphoma?",
          "What was the mean of three regimens?",
          "What was the risk factor for relapsed diffuse large B-cell lymphoma",
          "What was the risk factor for relapsed diffuse large B-cell lymphoma",
          "What percentage of patients had relapsed after autologous stem cell transplant?",
          "What treatment did 34% of patients receive?"
        ]
      }
    }
  },
  "asked": {
    "How many patients developed deep vein thromboses?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0002561211585998535,
        "ground_truth": {
          "Three": {
            "bertscore": 0.7017643451690674,
            "f1": 0
          },
          "Three patients": {
            "bertscore": 0.6894558668136597,
            "f1": 0
          }
        }
      }
    },
    "How many patients developed treatment-related acute myelogenous leukemia?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.008941650390625,
        "ground_truth": {
          "two": {
            "bertscore": 0.7294577360153198,
            "f1": 0
          },
          "two heavily pretreated patients": {
            "bertscore": 0.6837580800056458,
            "f1": 0
          }
        }
      }
    },
    "How long did the patients receive treatment for a myelogenous leukemia?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.05251359939575195,
        "ground_truth": {
          "3.7 and 12 months": {
            "bertscore": 0.6367194652557373,
            "f1": 0
          }
        }
      }
    },
    "What did three patients develop after treatment?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.02012234926223755,
        "ground_truth": {
          "deep vein thromboses": {
            "bertscore": 0.6401556134223938,
            "f1": 0
          }
        }
      }
    },
    "What did two patients with pretreatment develop?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "diffuse large B-cell lymphoma",
        "answerability": 0.9117550253868103,
        "ground_truth": {
          "treatment-related acute myelogenous leukemia": {
            "bertscore": 0.7448334693908691,
            "f1": 0
          }
        }
      }
    },
    "What is another name for acute myelogenous leukemia?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0008260607719421387,
        "ground_truth": {
          "myelodysplasia": {
            "bertscore": 0.6188271641731262,
            "f1": 0
          }
        }
      }
    },
    "What did the patients receive after 3.7 and 12 months of treatment?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00231170654296875,
        "ground_truth": {
          "therapy": {
            "bertscore": 0.6846924424171448,
            "f1": 0
          }
        }
      }
    }
  }
}